Delivery Order SPE2DB24D1104-SPE2DB24FYAD1

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,451.40 firm fixed price delivery order is for the provision of the prescription medication Trulicity 1.5 mg/0.5 ml pen, with a completion date of June 10, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription medication Trulicity 1.5 mg/0.5 ml pen 0.5 ml. The $11,727.62 firm fixed price contract was awarded on April 22, 2024 by the Defense Logistics Agency (DLA), with an ultimate completion date of April 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication Trulicity 1.5 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a $1,741.68 Firm Fixed Price delivery order with a completion date of July 8, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for providing a comprehensive range of...
This federal contract award has been granted to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of Trulicity 3 mg/0.5 ml pen 0.5 ml, a prescription medication, to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract, valued at $1,741.68, is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $5,727.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide the pharmaceutical product Trulicity 1.5 mg/0.5 ml pen, 0.5 ml. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which enables the DLA to efficiently...
This federal contract award is for the delivery of the pharmaceutical product Trulicity (3 mg/0.5 ml pen, 0.5 ml) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $14,806.24 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through February 12, 2024 and was not designated as a set-aside award. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,639.98 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) for the medication Trulicity 4.5 mg/0.5 ml pen 0.5 ml. The contract has a completion date of May 22, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Trulicity 1.5 mg/0.5 mL pen. The firm fixed price contract has a ceiling value of $2,322.24 and a period of performance through April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,741.68 and a period of performance through June 28, 2024. This is a firm fixed-price delivery order contract, without a set-aside designation. Amerisourcebergen holds a significant Indefinite...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAD1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of the prescription medication Trulicity (1.5 mg/0.5 ml pen) to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,708.59 and an ultimate completion date of July 10, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This specific contract award does not have a set-aside designation.

Generated 10/8/24, 9:09 AM